Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $178.53
Key levels
Resistance$178.53
Resistance$153.53
Support$116.50
Support$82.80
Latest news & SEC filings
EarningsTwist Bioscience Posts Q4 and Full-Year Results for FY2026
EarningsTwist Bioscience posts quarterly loss of $0.32 a share, revenue $126.644M
SEC FilingTwist Bioscience Corp filed a report on a major company event (Form 8-K)
GuidanceTwist Bioscience forecasts Q1 sales of $130M-$132M, above $126.354M estimate
GuidanceTwist Bioscience forecasts FY2027 sales of $550M-$560M
All TWST news →Twist Bioscience makes synthetic DNA using a silicon-chip-based writing process. Its products include synthetic genes, gene fragments, oligo pools, next-generation sequencing sample prep tools, and antibody discovery services. Customers are in healthcare, chemicals and materials, food and agriculture, and academic research, and include biotech, pharma, diagnostic and agricultural companies. It operates in the United States and sells globally.
Based on the company's 10-K filed Nov 17, 2025.
Nasdaq · Healthcare
SEPT Low Target
$45.00
SEPT Mid Target
$150.00
SEPT High Target
$215.00
Analyst Consensus
$150.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for TWST.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$117.11
23
Moat Score
NONE
3/9
Piotroski Score
25.5
Altman Z-Score
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Cho Dennis | officer | Sale | 949 | $128K | Nov 3, 2026 |
| Finn Patrick John | officer | Sale | 2,565 | $347K | Nov 3, 2026 |
| Green Paula | officer | Sale | 1,007 | $136K | Nov 3, 2026 |
| Leproust Emily M. | director officer | Sale | 4,573 | $619K | Nov 3, 2026 |
| WERNER ROBERT F. | officer | Sale | 148 | $20K | Nov 3, 2026 |
| Finn Patrick John | officer | Sale | 2,245 | $302K | Oct 23, 2026 |
| Leproust Emily M. | director officer | Sale | 1,840 | $369K | Oct 5, 2026 |
| Leproust Emily M. | director officer | Sale | 481 | $97K | Oct 5, 2026 |
| Leproust Emily M. | director officer | Sale | 1,017 | $206K | Oct 5, 2026 |
| Leproust Emily M. | director officer | Sale | 432 | $88K | Oct 5, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
20.3%
3yr Revenue CAGR
22.8%
EPS Growth YoY
63.89%
FCF Growth YoY
-9.3%
Revenue Trend
STRONG
SEPT Investing tracks real-time dark pool institutional trades for TWST, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:01:09 | $106.50 | 1,800 | $$192K | BUY |
| 14:01:09 | $106.50 | 1,800 | $$192K | BUY |
| 14:01:09 | $106.50 | 1,800 | $$192K | BUY |
| 14:00:31 | $106.27 | 1,133 | $$120K | BUY |
| 13:47:57 | $103.00 | 1,000 | $$103K | SELL |
5 dark pool trades shown · $$799K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing provides real-time options flow tracking for TWST, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $80 | Nov 20 | 9 | $$35 | 1 | SWEEP |
| PUT | $80 | Nov 20 | 9 | $$70 | 2 | SWEEP |
| CALL | $160 | Dec 18 | 37 | $$3360 | 3 | SWEEP |
| PUT | $125 | Nov 20 | 9 | $$1704 | 2 | SWEEP |
| CALL | $185 | Dec 18 | 37 | $$112.3K | 210 | BLOCK |
5 options trades shown · 40% calls
Unusual activity, GEX levels, max pain, and dealer positioning
SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for TWST. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
SEPT Brain on $TWST -- Bearish TWST pushed to $69.20, past $62.92 and $65.09 and $67.25 targets then reversed hard -- 95% selling erased the gains. Uptrend holds while above $66.06. $75 psychological...
Join 3,500+ traders discussing TWST in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
SEPT's Trading AI has generated a free, downloadable PDF research report for Twist Bioscience Corp (TWST) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Twist Bioscience Corp (TWST) is at $122.59, down 7.22% (-$9.54) at the Nov 11, 2026 close.
Latest TWST news — Nov 12, 2026: Twist Bioscience Posts Q4 and Full-Year Results for FY2026 · Nov 12, 2026: Twist Bioscience posts quarterly loss of $0.32 a share, revenue $126.644M
The average analyst price target for TWST is $150.00, ranging from $45 to $215, based on 12 analysts. Latest: TD Cowen maintains on Oct 13, 2026.
Analyst ratings for TWST: 1 Buy, 24 Hold, 0 Sell — consensus Hold.
TWST last reported on Aug 3, 2026: EPS -$0.56 vs -$0.51 expected — a miss of 10.6%.
TWST does not currently pay a dividend.
Support: $116.50, $82.80, $63.99. Resistance: $153.53, $178.53, $200.31.
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
Nov 12, 2026: Twist Bioscience Posts Q4 and Full-Year Results for FY2026 · Nov 12, 2026: Twist Bioscience posts quarterly loss of $0.32 a share, revenue $126.644M · Nov 12, 2026: Twist Bioscience Corp filed a report on a major company event (Form 8-K)